A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway
Lorenz Lehmann(German Cancer Research Center), Johannes Backs(Heidelberg University), Daniel Finke(Heidelberg University), Julia Ritterhoff(University of Washington), Mariya Kronlage(Heidelberg University), Albert H von der Lieth(Heidelberg University), Mirko Völkers(German Cancer Research Center), Matthias Dewenter(Heidelberg University), Sven W. Sauer(Heidelberg University), Jutta Krebs-Haupenthal(Heidelberg University), Andrea Schmidt(Heidelberg University), Eileen E. M. Furlong(European Bioinformatics Institute), Benjamin Meder(Heidelberg University), Patrick Most(Thomas Jefferson University), Michael Kohlhaas(Saarland University), Christoph Maack(Comprehensive Cancer Center Mainfranken), Hugo A. Katus(Heidelberg University), Andreas Jungmann(Heidelberg University), Michael Wagner(University Hospital Carl Gustav Carus), Ali El‐Armouche(Universität Hamburg), Ulrike Oehl(Heidelberg University), Oliver J. Müller(Heidelberg University), Juan E. Camacho Londoño(Heidelberg University), Carsten Sticht(Heidelberg University), Christian T. Thiel(University Medical Center Groningen), Stephan Herzig(Heidelberg University), Marc Freichel(Heidelberg University), Michael M. Kreußer(Heidelberg University), Axel Horsch(Heidelberg University), Viviana Sramek(Heidelberg University), Lars S. Maier(University Hospital Regensburg), Qiang Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Tao He(Heidelberg University), Michaela Schäfer(Heidelberg University), Norbert Gretz(Heidelberg University), Zegeye Hailu Jebessa(Heidelberg University), Hermann‐Josef Gröne, Alexander Nickel(Saarland University)
Cited by 137
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
European Society of Cardiology: cardiovascular disease statistics 2021
|European Heart Journal|2021|1.1k
Myocardial infarction accelerates atherosclerosis
|Nature|2012|1.1k
Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society
|European Journal of Heart Failure|2020|767